As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
New special issue: Translating the microbiome
Our special issue on ‘Translating the microbiome in health and disease’, guest edited by Ramnik Xavier has now launched.
SARS-CoV-2 vaccine targets
Asaf Poran and colleagues provide a comprehensive set of CD4+ and CD8+ T cell epitopes spanning the entire SARS-CoV-2 genome.
Plasma ctDNA and prostate cancer
Niall Corcoran and colleagues show that detection of ctDNA in patients with prostate cancer before surgery is associated with lower metastasis-free survival.
Strain-level epidemiology of microbial communities
Curtis Huttenhower and colleagues discuss our current knowledge of microbiome strains in the human body and their links to health and disease.
Reviews, Research Highlights and Commentaries
Read authoritative Reviews, Opinions and other content commissioned by the Genome Medicine Editors from leading researchers:
Commentaries (including Editorials, Comments, Opinions, Q&As and Meeting reports)
Articles
-
-
Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer
-
Mitochondrial DNA copy number can influence mortality and cardiovascular disease via methylation of nuclear DNA CpGs
-
Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1
-
Understanding the impact of antibiotic perturbation on the human microbiome
-
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
-
A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications
-
Gut microbiome-host interactions in health and disease
-
Constructing narratives of heroism and villainy: case study of Myriad's BRACAnalysis® compared to Genentech's Herceptin®
-
Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials
Focus: Immunology in Health and Disease
Read the latest papers on immunology across BMC flagship journals.
Association between the cytokine storm, immune cell dynamics, and viral replicative capacity in hyperacute HIV infection
Daniel M. Muema et al.
Published in BMC Medicine 25 March 2020
The role of T cell trafficking in CTLA-4 blockade-induced gut immunopathology
Shashuang Zhang et al.
Published in BMC Biology 17 March 2020
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
Markus W. Löffler et al.
Published in Genome Medicine 30 April 2019
Host-associated microbiomes are predicted by immune system complexity and climate
Douglas C. Woodhams et al.
Published in Genome Biology 03 February 2020
Aims and scope
Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries.
Article collections
Special issue
Clinical interpretation of genome variation
Guest editors: Heidi Rehm and Douglas Fowler
Collection
A decade of Genome Medicine
Special issue
Tumor immune microenvironment and immunotherapy
Guest editors: Zlatko Trajanoski and Noel de Miranda
Special issue
From genome integrity to cancer
Guest editor: Serena Nik-Zainal
From the blog
-
-
World Heart Day 2020: #UseYourHeart to fight COVID-19
21 September 2020
-
Building trust in peer review: A Q&A with Dr Mario Malički
18 September 2020
- Editorial Board
- Editorial Team
- Sign up for article alerts and news from this journal
- Contact us
-
Announcements
C19 Rapid Review Initiative
Genome Medicine has joined the C19 Rapid Review Initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here.
Submissions from medRxiv
Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.
Portable peer review
To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.
COVID-19 submissions
In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.
Follow
2019 Journal Metrics
-
Citation Impact
10.675 - 2-year Impact Factor
10.637 - 5-year Impact Factor
1.833 - Source Normalized Impact per Paper (SNIP)
5.084 - SCImago Journal Rank (SJR)
